| Primary |
| Atrial Fibrillation |
27.6% |
| Arrhythmia |
16.1% |
| Pneumonia |
6.9% |
| Hypertension |
5.7% |
| Bronchitis Chronic |
4.6% |
| Gastritis |
4.6% |
| Hypertrophic Cardiomyopathy |
3.4% |
| Tachycardia Paroxysmal |
3.4% |
| Blood Cholesterol Increased |
2.3% |
| Cardiac Failure Chronic |
2.3% |
| Cerebral Infarction |
2.3% |
| Dementia |
2.3% |
| Gastric Ulcer |
2.3% |
| Gout |
2.3% |
| Hyperlipidaemia |
2.3% |
| Hyperuricaemia |
2.3% |
| Ill-defined Disorder |
2.3% |
| Thrombosis Prophylaxis |
2.3% |
| Ulcer Haemorrhage |
2.3% |
| Ventricular Arrhythmia |
2.3% |
|
| Palpitations |
12.8% |
| Atrial Fibrillation |
7.7% |
| Hypersensitivity |
7.7% |
| Hypoglycaemia |
7.7% |
| Stent Embolisation |
7.7% |
| Vision Blurred |
7.7% |
| Constipation |
5.1% |
| Loss Of Consciousness |
5.1% |
| Pneumonia Aspiration |
5.1% |
| Unevaluable Event |
5.1% |
| Ventricular Tachycardia |
5.1% |
| Accidental Overdose |
2.6% |
| Altered State Of Consciousness |
2.6% |
| Anaemia |
2.6% |
| Arteriospasm Coronary |
2.6% |
| Blood Pressure Inadequately Controlled |
2.6% |
| Bradycardia |
2.6% |
| Cardiac Pacemaker Insertion |
2.6% |
| Cardio-respiratory Arrest |
2.6% |
| Drug Effect Incomplete |
2.6% |
|
| Secondary |
| Atrial Fibrillation |
50.0% |
| Drug Use For Unknown Indication |
18.8% |
| Cardiac Disorder |
5.5% |
| Angina Pectoris |
3.1% |
| Supraventricular Tachycardia |
3.1% |
| Rheumatoid Arthritis |
2.3% |
| Arrhythmia |
1.6% |
| Catheter Related Infection |
1.6% |
| Cytomegalovirus Infection |
1.6% |
| Gastric Ulcer Haemorrhage |
1.6% |
| Hypercalcaemia |
1.6% |
| Pain |
1.6% |
| Product Used For Unknown Indication |
1.6% |
| Skin Ulcer |
1.6% |
| Anxiety |
0.8% |
| Arteriosclerosis Obliterans |
0.8% |
| Blood Cholesterol Increased |
0.8% |
| Blood Glucose Increased |
0.8% |
| Chronic Myeloid Leukaemia |
0.8% |
| Insomnia |
0.8% |
|
| Pain |
20.8% |
| Hip Fracture |
10.4% |
| Adverse Reaction |
8.3% |
| Anaemia |
8.3% |
| Thoracic Vertebral Fracture |
6.3% |
| Agranulocytosis |
4.2% |
| Atrial Fibrillation |
4.2% |
| Cardiac Disorder |
4.2% |
| Myocardial Infarction |
4.2% |
| Renal Disorder |
4.2% |
| Sleep Apnoea Syndrome |
4.2% |
| Visual Impairment |
4.2% |
| Alopecia |
2.1% |
| Drug Effect Incomplete |
2.1% |
| Drug Hypersensitivity |
2.1% |
| Femur Fracture |
2.1% |
| Hyperkalaemia |
2.1% |
| Hypoacusis |
2.1% |
| Malaise |
2.1% |
| Palpitations |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.4% |
| Atrial Fibrillation |
15.0% |
| Product Used For Unknown Indication |
13.2% |
| Hypertension |
11.7% |
| Rheumatoid Arthritis |
6.7% |
| Pain |
4.5% |
| Abdominal Discomfort |
3.0% |
| Anxiety |
2.5% |
| Osteoporosis |
2.5% |
| Hypothyroidism |
2.2% |
| Polycystic Ovaries |
2.2% |
| Cardiac Disorder |
2.0% |
| Arrhythmia |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Arthritis |
1.5% |
| Depression |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Metastases To Central Nervous System |
1.5% |
| Blood Cholesterol Increased |
1.2% |
| Crohn's Disease |
1.2% |
|
| Somnolence |
8.5% |
| Weight Decreased |
8.5% |
| Oxygen Saturation Decreased |
6.8% |
| Pneumonia |
6.8% |
| Pruritus |
6.8% |
| Rash Maculo-papular |
6.8% |
| Atrial Septal Defect |
5.1% |
| Supraventricular Tachycardia |
5.1% |
| Syncope |
5.1% |
| Thrombosis |
5.1% |
| Weight Increased |
5.1% |
| Cholelithiasis |
3.4% |
| Dizziness |
3.4% |
| Flushing |
3.4% |
| Haematemesis |
3.4% |
| Haemorrhoids |
3.4% |
| Headache |
3.4% |
| Hyperhidrosis |
3.4% |
| Hypoaesthesia |
3.4% |
| Loss Of Consciousness |
3.4% |
|
| Interacting |
| Bronchitis Chronic |
20.0% |
| Gastritis |
20.0% |
| Pneumonia |
20.0% |
| Arrhythmia |
10.0% |
| Atrial Fibrillation |
10.0% |
| Cardiac Failure Chronic |
10.0% |
| Thrombosis Prophylaxis |
10.0% |
|
| Pneumonia Aspiration |
100.0% |
|
